SNCA conformer propagation across PD, DLB, and MSA

Mechanistic description

Shared mechanism across PD, DLB, MSA: SNCA mutations and alpha-synuclein inclusions define neuronal Lewy pathology in PD/DLB, while MSA shows oligodendroglial alpha-synuclein inclusions. A shared misfolded-alpha-synuclein seeding axis likely diverges by host cell proteostasis and lipid environment, explaining overlapping proteinopathy with distinct anatomy.

Falsifiable prediction: Patient-derived alpha-synuclein seeds from PD/DLB and MSA should induce different neuronal-versus-oligodendroglial inclusion ratios, but ASO knockdown of SNCA should lower seed amplification signal by at least 50% in all three seed classes.

Proposed experiment: Expose human dopaminergic neuron/oligodendrocyte co-cultures to characterized PD, DLB, and MSA seed extracts; treat with SNCA ASO or control; quantify pS129-SNCA, RT-QuIC/seed amplification, oligodendroglial stress, and neuronal survival.

Cross-disease confidence rationale: Canonical genetics/pathology in PD plus direct MSA glial inclusion evidence.

Internal SciDEX support: SciDEX support query found 44 matching hypotheses across 5 disease labels, including 44 with debate_count > 0.

Generated by task ffd81f3a-7f04-4db1-8547-1778ce030e89 as a cross-disease mechanism synthesis, not a single-disease hypothesis renamed as multi-disease.

Mechanism / pathway

SNCA
→
Alpha-synuclein aggregation, seeding, and cell-type-specific inclusion biology
→
multi

Evidence for (4)

SNCA mutation was identified in familial Parkinson's disease.

PMID:9197268 1997
Alpha-synuclein is present in Lewy bodies.

PMID:9278044 1997
Alpha-synuclein immunoreactivity is present in MSA glial cytoplasmic inclusions.

PMID:9682846 1998
Host cell proteostasis capacity and membrane lipid environment interact to determine whether alpha-synuclein seeds induce neuronal Lewy pathology or oligodendroglial cytoplasmic inclusions.

PMID:20846907

Evidence against (2)

PMID:41814068 2026
PMID:37052776 2023

Evidence matrix

4 supporting 0 contradicting

100% supporting

Supporting

SNCA mutation was identified in familial Parkinson's disease. PMID:9197268 · 1997 · 10.1126/science.276.5321.2045
Alpha-synuclein is present in Lewy bodies. PMID:9278044 · 1997 · 10.1038/42166
Alpha-synuclein immunoreactivity is present in MSA glial cytoplasmic inclusions. PMID:9682846 · 1998 · 10.1016/s0304-3940(98)00407-8
Host cell proteostasis capacity and membrane lipid environment interact to determine whether alpha-synuclein seeds induce neuronal Lewy pathology or oligodendroglial cytoplasmic inclusions. PMID:20846907

Contradicting

No contradicting evidence recorded.

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 d5ef8296-a250-4d18-9280-ab16b7e9999a 0.471 trust 0.50 · rel 1.00 · 71d
#2 fc10f229-2053-46f1-9be1-2ffadbf994e0 0.471 trust 0.50 · rel 1.00 · 71d
#3 79add740-c212-4930-9577-bf9611f934c8 0.471 trust 0.50 · rel 1.00 · 71d

3 total ranked · scidex.hypotheses.evidence_ranking

Cite this hypothesis

Citation

etl-backfill (2026). SNCA conformer propagation across PD, DLB, and MSA. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-cross-synth-snca-synucleinopathy

BibTeX

@misc{scidex_hypothesis_hcrosssy,
  title        = {SNCA conformer propagation across PD, DLB, and MSA},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-cross-synth-snca-synucleinopathy},
  note         = {SciDEX artifact hypothesis:h-cross-synth-snca-synucleinopathy}
}